1. Stewart PM, Corrie J, Seckl JR, Edwards CR, Padfield PL. A rational approach for assessing the hypothalamo-pituitary-adrenal axis. Lancet. 1988; 1:1208–10.
Article
2. Dorin RI, Qualls CR, Crapo LM. Diagnosis of adrenal insufficiency. Ann Intern Med. 2003; 139:194–204.
Article
3. Brien TG. Human corticosteroid binding globulin. Clin Endocrinol (Oxf). 1981; 14:193–212.
Article
4. Coolens JL, Van Baelen H, Heyns W. Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem. 1987; 26:197–202.
Article
5. Perogamvros I, Ray DW, Trainer PJ. Regulation of cortisol bioavailability: effects on hormone measurement and action. Nat Rev Endocrinol. 2012; 8:717–27.
Article
6. Hammond GL. Determinants of steroid hormone bioavailability. Biochem Soc Trans. 1997; 25:577–82.
Article
7. Arafah BM, Nishiyama FJ, Tlaygeh H, Hejal R. Measurement of salivary cortisol concentration in the assessment of adrenal function in critically ill subjects: a surrogate marker of the circulating free cortisol. J Clin Endocrinol Metab. 2007; 92:2965–71.
Article
8. Wood P. Salivary steroid assays: research or routine? Ann Clin Biochem. 2009; 46(Pt 3):183–96.
9. Groschl M. Current status of salivary hormone analysis. Clin Chem. 2008; 54:1759–69.
Article
10. Dorn LD, Lucke JF, Loucks TL, Berga SL. Salivary cortisol reflects serum cortisol: analysis of circadian profiles. Ann Clin Biochem. 2007; 44(Pt 3):281–4.
Article
11. Galbois A, Rudler M, Massard J, Fulla Y, Bennani A, Bonnefont-Rousselot D, et al. Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred. J Hepatol. 2010; 52:839–45.
Article
12. Inder WJ, Dimeski G, Russell A. Measurement of salivary cortisol in 2012: laboratory techniques and clinical indications. Clin Endocrinol (Oxf). 2012; 77:645–51.
13. Riad-Fahmy D, Read GF, Walker RF. Salivary steroid assays for screening endocrine function. Postgrad Med J. 1980; 56(Suppl 1):75–8.
14. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, et al. The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008; 93:1526–40.
Article
15. Ceccato F, Barbot M, Zilio M, Ferasin S, Occhi G, Daniele A, et al. Performance of salivary cortisol in the diagnosis of Cushing’s syndrome, adrenal incidentaloma, and adrenal insufficiency. Eur J Endocrinol. 2013; 169:31–6.
Article
16. Langelaan MLP, Kisters JMH, Oosterwerff MM, Boer AK. Salivary cortisol in the diagnosis of adrenal insufficiency: cost efficient and patient friendly. Endocr Connect. 2018; 7:560–6.
Article
17. Deutschbein T, Broecker-Preuss M, Flitsch J, Jaeger A, Althoff R, Walz MK, et al. Salivary cortisol as a diagnostic tool for Cushing’s syndrome and adrenal insufficiency: improved screening by an automatic immunoassay. Eur J Endocrinol. 2012; 166:613–8.
Article
18. Restituto P, Galofre JC, Gil MJ, Mugueta C, Santos S, Monreal JI, et al. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders. Clin Biochem. 2008; 41:688–92.
Article
19. Deutschbein T, Unger N, Mann K, Petersenn S. Diagnosis of secondary adrenal insufficiency in patients with hypothalamic-pituitary disease: comparison between serum and salivary cortisol during the high-dose short synacthen test. Eur J Endocrinol. 2009; 160:9–16.
Article
20. Karpman MS, Neculau M, Dias VC, Kline GA. Defining adrenal status with salivary cortisol by gold-standard insulin hypoglycemia. Clin Biochem. 2013; 46:1442–6.
Article
21. Contreras LN, Arregger AL, Persi GG, Gonzalez NS, Cardoso EM. A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin. Clin Endocrinol (Oxf). 2004; 61:675–82.
Article
22. Laudat MH, Cerdas S, Fournier C, Guiban D, Guilhaume B, Luton JP. Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function. J Clin Endocrinol Metab. 1988; 66:343–8.
Article
23. Cornes MP, Ashby HL, Khalid Y, Buch HN, Ford C, Gama R. Salivary cortisol and cortisone responses to tetracosactrin (synacthen). Ann Clin Biochem. 2015; 52(Pt 5):606–10.
Article
24. Raff H, Homar PJ, Skoner DP. New enzyme immunoassay for salivary cortisol. Clin Chem. 2003; 49:203–4.
Article
25. Kosak M, Hana V, Hill M, Simunkova K, Lacinova Z, Krsek M, et al. Serum cortisol seems to be a more appropriate marker for adrenocortical reserve evaluation in ACTH test in comparison to salivary cortisol. Physiol Res. 2014; 63:229–36.
Article
26. Simunkova K, Hampl R, Hill M, Doucha J, Starka L, Vondra K. Salivary cortisol in low dose (1 microg) ACTH test in healthy women: comparison with serum cortisol. Physiol Res. 2007; 56:449–53.
27. Marcus-Perlman Y, Tordjman K, Greenman Y, Limor R, Shenkerman G, Osher E, et al. Low-dose ACTH (1 microg) salivary test: a potential alternative to the classical blood test. Clin Endocrinol (Oxf). 2006; 64:215–8.
28. Nolan BJ, Sorbello J, Brown N, Dimeski G, Inder WJ. Characterization of the serum and salivary cortisol response to the intravenous 250 μg ACTH 1–24 stimulation test. Endocrine. 2018; 59:520–8.
Article
29. Dickstein G, Shechner C, Nicholson WE, Rosner I, Shen-Orr Z, Adawi F, et al. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab. 1991; 72:773–8.
Article
30. Cho HY, Kim JH, Kim SW, Shin CS, Park KS, Kim SW, et al. Different cut-off values of the insulin tolerance test, the high-dose short Synacthen test (250 μg) and the low-dose short Synacthen test (1 μg) in assessing central adrenal insufficiency. Clin Endocrinol (Oxf). 2014; 81:77–84.
Article
31. Elder CJ, Harrison RF, Cross AS, Vilela R, Keevil BG, Wright NP, et al. Use of salivary cortisol and cortisone in the high- and low-dose synacthen test. Clin Endocrinol (Oxf). 2018; 88:772–8.
Article
32. Arafah BM. Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. J Clin Endocrinol Metab. 2006; 91:3725–45.
Article
33. Meuwese CL, Carrero JJ. Chronic kidney disease and hypothalamic-pituitary axis dysfunction: the chicken or the egg? Arch Med Res. 2013; 44:591–600.
Article
34. Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med. 2004; 350:1629–38.
Article
35. Arregger AL, Cardoso EM, Zucchini A, Aguirre EC, Elbert A, Contreras LN. Adrenocortical function in hypotensive patients with end stage renal disease. Steroids. 2014; 84:57–63.
Article